Literature DB >> 22609451

A prototype tissue engineered blood vessel using amniotic membrane as scaffold.

Po-Han Lee1, Shu-Huai Tsai, Lih Kuo, Chih-Yung Hwang, Chan-Yen Kuo, Vivian C Yang, Jan-Kan Chen.   

Abstract

In this study, we used amniotic membrane (AM), a natural extracellular matrix, as a scaffold for the fabrication of tissue engineered blood vessels (TEBVs). The inner surface of the denuded glutaraldehyde cross-linked AM tube was endothelialized with porcine vascular endothelial cells (ECs) and subjected to a physiological (12 dynecm(-2)) shear stress (SS) for 2 and 4 days. The results showed that after applying SS, an intact EC monolayer was maintained in the lumen surface of the TEBV. The ECs were aligned with their long axis parallel to the blood flow. The immunofluorescent microscopy showed that the intercellular junctional proteins, PECAM-1 and VE-cadherin, were surrounding the EC periphery and were better developed and more abundant in SS-treated TEBVs than the static controls. The Western blot indicated that the expressions of PECAM-1 and VE-cadherin were increased by 72 ± 9% and 67 ± 7%, respectively, after shear stress treatment. The distribution pattern of integrin β1 was mainly at the interface of ECs and AM in static TEBVs but it was extended to the cell-cell junctions after SS treatment. The SS promoted the expression of integrin α(v)β(3) without altering its distribution in TEBV. The results suggest that glutaraldehyde cross-linked AM tube can potentially be used as a scaffold biomaterial for TEBV fabrication. Most importantly, the use of an AM tube shortened the TEBV fabrication.
Copyright © 2012 Acta Materialia Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22609451     DOI: 10.1016/j.actbio.2012.05.012

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  6 in total

1.  An aorta ECM extracted hydrogel as a biomaterial in vascular tissue engineering application.

Authors:  Khadijeh Baaji; Mohamad Pezeshki-Modaress; Sarah Rajabi
Journal:  Prog Biomater       Date:  2022-05-18

Review 2.  Building Scaffolds for Tubular Tissue Engineering.

Authors:  Alexander J Boys; Sarah L Barron; Damyan Tilev; Roisin M Owens
Journal:  Front Bioeng Biotechnol       Date:  2020-12-10

3.  The Combination of Tissue-Engineered Blood Vessel Constructs and Parallel Flow Chamber Provides a Potential Alternative to In Vivo Drug Testing Models.

Authors:  Wanjiku Njoroge; Andrea C Hernández Hernández; Faiza Idris Musa; Robert Butler; Alan G S Harper; Ying Yang
Journal:  Pharmaceutics       Date:  2021-03-05       Impact factor: 6.321

Review 4.  Applications of Human Amniotic Membrane for Tissue Engineering.

Authors:  Mathilde Fénelon; Sylvain Catros; Christophe Meyer; Jean-Christophe Fricain; Laurent Obert; Frédéric Auber; Aurélien Louvrier; Florelle Gindraux
Journal:  Membranes (Basel)       Date:  2021-05-25

Review 5.  Trends in tissue engineering for blood vessels.

Authors:  Judee Grace Nemeno-Guanzon; Soojung Lee; Johan Robert Berg; Yong Hwa Jo; Jee Eun Yeo; Bo Mi Nam; Yong-Gon Koh; Jeong Ik Lee
Journal:  J Biomed Biotechnol       Date:  2012-11-08

6.  The Tissue-Engineered Vascular Graft-Past, Present, and Future.

Authors:  Samand Pashneh-Tala; Sheila MacNeil; Frederik Claeyssens
Journal:  Tissue Eng Part B Rev       Date:  2015-10-08       Impact factor: 6.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.